Medical Market Report

Global Immune Repertoire Sequencing Market By Type (Pyro-Sequencing, Dye-Terminating Sequencing, Semiconductor Sequencing, and Others), By Application (Biomarker Discovery, Infectious Diseases, Vaccine Development and Efficacy, Cancer Immunotherapy, Autoimmune Disease, Transplant Rejection and Tolerance, and Others), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 139050
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Immune Repertoire Sequencing Market is estimated to be valued US$ XX.X million in 2019. The report on Immune Repertoire Sequencing Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global immune repertoire sequencing market is segmented on the basis of Type, Application, and geography.

    Europe market was valued at US$ XX.X million in 2018 and is projected to reach US$ XX.X million in 2029, and register a CAGR of X.X% during the forecast period, according to a new Market.us (Prudour Research) study.

    Immune Repertoire Sequencing Market Scope:

    By type, the market is segmented into Pyro-Sequencing, Dye-Terminating Sequencing, Semiconductor Sequencing, and Others. By Application, the market is divided into Biomarker Discovery, Infectious Diseases, Vaccine Development and Efficacy, Cancer Immunotherapy, Autoimmune Disease, Transplant Rejection and Tolerance, and Others.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include ArcherDX, Junom Therapeutics, Roche Holding, Illumina, ThermoFisher Scietific, Pacific Biosciences, CD Genomics, Atreca, and Adaptive Biotechnologies.

    Key Market Segments

    Type

    Pyro-Sequencing

    Dye-Terminating Sequencing

    Semiconductor Sequencing

    Others

    Application

    Biomarker Discovery

    Infectious Diseases

    Vaccine Development and Efficacy

    Cancer Immunotherapy

    Autoimmune Disease

    Transplant Rejection and Tolerance

    Others

    Key Market Players included in the report:

    ArcherDX

    Junom Therapeutics

    Roche Holding

    Illumina

    ThermoFisher Scietific

    Pacific Biosciences

    CD Genomics

    Atreca

    Adaptive Biotechnologies

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Immune Repertoire Sequencing Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Immune Repertoire Sequencing Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Immune Repertoire Sequencing Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Immune Repertoire Sequencing Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Immune Repertoire Sequencing Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Immune Repertoire Sequencing Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Immune Repertoire Sequencing sub-markets, depending on key regions (various vital states).
    To analyze Immune Repertoire Sequencing Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Immune Repertoire Sequencing Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Immune Repertoire Sequencing Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Immune Repertoire Sequencing Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope
    

    2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players
    

    3. Global Immune Repertoire Sequencing Market Overview
    

    3.1. Immune Repertoire Sequencing Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges
    

      3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy
    

    4. Global Immune Repertoire Sequencing Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Immune Repertoire Sequencing Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Pyro-Sequencing
    

      4.4. Dye-Terminating Sequencing
    

      4.5. Semiconductor Sequencing
    

      4.6. Others
    

    5. Global Immune Repertoire Sequencing Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Immune Repertoire Sequencing Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Biomarker Discovery
    

      5.4. Infectious Diseases
    

      5.5. Vaccine Development and Efficacy
    

      5.6. Cancer Immunotherapy
    

      5.7. Autoimmune Disease
    

      5.8. Transplant Rejection and Tolerance
    

      5.9. Others
    

    6. Global Immune Repertoire Sequencing Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Immune Repertoire Sequencing Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Immune Repertoire Sequencing Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Immune Repertoire Sequencing Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Immune Repertoire Sequencing Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Immune Repertoire Sequencing Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    

    7. Global Immune Repertoire Sequencing Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. ArcherDX
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments
    

      7.4. Junom Therapeutics
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments
    

      7.5. Roche Holding
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments
    

      7.6. Illumina
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments
    

      7.7. ThermoFisher Scietific
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments
    

      7.8. Pacific Biosciences
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
    

      7.9. CD Genomics
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
    

      7.10. Atreca
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments
    

      7.11. Adaptive Biotechnologies
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.